Puma Biotechnology Inc (PBYI)
4.79
-0.04
(-0.83%)
USD |
NASDAQ |
Apr 25, 11:20
Puma Biotechnology Price: 4.79 for April 25, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 24, 2024 | 5.09 | 5.135 | 4.77 | 4.83 | 309785.0 |
Apr 23, 2024 | 5.17 | 5.34 | 5.10 | 5.13 | 293869.0 |
Apr 22, 2024 | 5.01 | 5.27 | 5.00 | 5.17 | 265410.0 |
Apr 19, 2024 | 4.92 | 5.08 | 4.90 | 5.01 | 290457.0 |
Apr 18, 2024 | 5.18 | 5.29 | 4.925 | 4.99 | 289054.0 |
Apr 17, 2024 | 5.10 | 5.30 | 5.05 | 5.17 | 248185.0 |
Apr 16, 2024 | 5.32 | 5.42 | 5.06 | 5.10 | 285862.0 |
Apr 15, 2024 | 5.30 | 5.43 | 5.25 | 5.35 | 266547.0 |
Apr 12, 2024 | 5.37 | 5.521 | 5.212 | 5.27 | 221709.0 |
Apr 11, 2024 | 5.51 | 5.65 | 5.46 | 5.49 | 145931.0 |
Apr 10, 2024 | 5.77 | 5.80 | 5.40 | 5.525 | 378662.0 |
Apr 09, 2024 | 5.61 | 6.055 | 5.59 | 5.83 | 552103.0 |
Apr 08, 2024 | 5.64 | 5.71 | 5.44 | 5.63 | 315266.0 |
Apr 05, 2024 | 5.49 | 5.84 | 5.42 | 5.66 | 405403.0 |
Apr 04, 2024 | 5.40 | 5.57 | 5.36 | 5.51 | 530286.0 |
Apr 03, 2024 | 5.24 | 5.35 | 5.10 | 5.35 | 337167.0 |
Apr 02, 2024 | 5.16 | 5.33 | 5.05 | 5.28 | 375493.0 |
Apr 01, 2024 | 5.42 | 5.42 | 5.12 | 5.28 | 400922.0 |
Mar 28, 2024 | 5.56 | 5.60 | 5.242 | 5.30 | 275380.0 |
Mar 27, 2024 | 5.63 | 5.74 | 5.38 | 5.58 | 357785.0 |
Mar 26, 2024 | 5.67 | 5.676 | 5.37 | 5.60 | 528485.0 |
Mar 25, 2024 | 5.31 | 5.72 | 5.25 | 5.59 | 738420.0 |
Mar 22, 2024 | 5.28 | 5.55 | 5.164 | 5.33 | 924299.0 |
Mar 21, 2024 | 4.67 | 5.39 | 4.62 | 5.35 | 1.168M |
Mar 20, 2024 | 4.40 | 4.74 | 4.24 | 4.695 | 599716.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.64
Minimum
May 11 2022
33.61
Maximum
Apr 25 2019
6.916
Average
6.275
Median
Price Benchmarks
ADMA Biologics Inc | 6.375 |
Regeneron Pharmaceuticals Inc | 882.93 |
Sarepta Therapeutics Inc | 126.09 |
CytomX Therapeutics Inc | 1.615 |
Mirum Pharmaceuticals Inc | 23.66 |
Price Related Metrics
PE Ratio | 10.64 |
PS Ratio | 0.9665 |
Price to Book Value | 4.321 |
Price to Free Cash Flow | 15.85 |
Earnings Yield | 9.39% |
Market Cap | 230.91M |
Operating PE Ratio | 6.847 |
Normalized PE Ratio | 10.35 |